Clinical considerations of CDK4/6 inhibitors in triple-negative breast cancer

作者：Runtian Wang, Kun Xu, Fangyan Gao, Jinyi Huang, Xiaoxiang Guan · 发表于：Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 年份：2021 · DOI：10.1016/j.bbcan.2021.188590 · 被引用次数：44 · 研究领域：Advanced Breast Cancer Therapies、HER2/EGFR in Cancer Research、Cancer-related Molecular Pathways